Home > Newsroom > 2008 > Notice of Upward Revision to First Half Year Consolidated Financial Forecasts for Fiscal Year
Main contents starts here
October 20, 2008
Takeda Pharmaceutical Company Limited
Notice of Upward Revision to First Half Year Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2009
Osaka, Japan, October 20, 2008 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today upward revision to first half year consolidated financial forecasts for fiscal year ending March 31, 2009. Takeda did not provide an updated forecast for the full-year consolidated financial forecasts for fiscal year ending March 31, 2009, as such figures are currently being determined and will be announced on November 4, 2009, at the time of the announcement of first half year financial results.
1. Revised First Half Year Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2009
(April 1, 2008 to September 30, 2008)
| Net Sales | Operating Income |
Ordinary Income |
Net Income for 1st Half |
||
| Previous Forecast (Announced on July 30, 2008) |
(A) | 760,000 | 50,000 | 65,000 | 50,000 |
| Revised Forecast | (B) | 805,000 | 85,000 | 100,000 | 70,000 |
| Changes in Amount | (B-A) |
+45,000 | +35,000 | +35,000 | +20,000 |
| Percentage of Change | (%) | +5.9 | +70.0 | +53.8 | +40.0 |
| Reference: Consolidated Results for First Half Year Ending March 31, 2008 |
708,468 | 264,905 | 333,696 | 218,011 | |
2. Reasons for Revision
The reason for the current revision is that net sales are now forecast to be higher than the previous forecast due to factors such as an increase in ethical drugs sales in Japan and more favorable exchange rates for the yen than forecast, which also resulted in an increase of sales in the overseas market. Operating income, ordinary income and net income for first half year are also expected to largely exceed the previous forecast due to the increase in net sales.
Note: The above forecast is based on certain information available to management at the time of announcement and actual operating results may differ from these projections.
# # #